Absence of mucocutaneous involvement, lower LDAS predict remission in SLE
Remission in patients with systemic lupus erythematosus (SLE) is predicted by the absence of mucocutaneous, renal and haematologic involvement, use of immunosuppressive drugs, and lower disease activity state (LDAS) early in the course of the disease, a study has shown. Additionally, older age predicts LDAS.